Diabetes DPG Public Library

The study by Elkind-Hirsch et, al., aimed to compare continuous glucose monitoring (CGM) to routine self-monitoring of blood glucose (SMBG) in women diagnosed with GDM during weeks 8 -26. 120 women were randomized to the intervention [CGM (n=80)] or control [SMBG 4 times/day and monthly blinded CGM (n=40)]. All participants received lifestyle and medication advice based on CGM interpretation and glucose monitoring until delivery. Results indicated that although no significant differences between groups in time spent in the glucose target range (TIR) 63–140 mg/dL were found (p = 0.37), participants in the intervention group experienced significantly lower rates of unscheduled caesarean section (20.0% vs. 44.4%, p = 0.046, V = 0.19) and preterm deliveries (6.8% vs. 18.4%, p = 0.041, V = 0.19). Neonates experienced lower large-for-gestational-age rates (5.0% vs. 18.4%, p = 0.019, V = 0.22) and lower admissions to the neonatal intensive care unit (22.5% vs. 44.7%, p = 0.013, V = 0.23) compared to the control group. The authors concluded that that CGM improved maternal and neonatal outcomes versus SMBG stating that the effect may be mediated by improved awareness of glycemic excursions and by facilitation of treatment regimen adjustments.

Elkind-Hirsch K, Armatta M, Griffen C, et al. Continuous glucose monitoring in early gestational diabetes improves maternal and neonatal outcomes—The Steady Sugar trial. Diabetes Obes Metab. 2026; 28(1): 691-700. doi:10.1111/dom.70254